Altogether, the aberrant expression of cyclin B1, particularly in tongue carcinomas, provides valuable information about the aggressiveness of the cancer and its potential to spread, aiding diagnosis, prognosis, and treatment decision making in OSCC patients. The gene discussed is CCNB1; the disease is tongue cancer.